Data Availability StatementNot applicable. in individual 1 and 2 respectively. Following nephrectomy, they were started on nivolumab. Patient 1 in the Bafetinib novel inhibtior beginning responded to the treatment with regression of metastatic lesions. However, following this early response, patient 1 who has been receiving nivolumab for more than 15?weeks, was noted to have a… Continue reading Data Availability StatementNot applicable. in individual 1 and 2 respectively. Following